Tilray Brands (TLRY) Income from Continuing Operations (2017 - 2026)

Tilray Brands (TLRY) reported Income from Continuing Operations of 25233000.0 for Q1 2026, up 96.82% on a YoY basis from 12820332.12 in Q1 2025, and up 42.01% quarter-over-quarter from 43509000.0 in Q4 2025.

Tilray Brands (TLRY) Income from Continuing Operations (2017 - 2026) Analysis & Trends

Tilray Brands has reported Income from Continuing Operations for 10 years, with the latest figure at 25233000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Income from Continuing Operations rose 96.82% year-over-year to 25233000.0; the trailing twelve-month figure through Feb 2026 stood at 680938000.0 (up 29.63% YoY), and the FY2025 full-year result was 1527170000.0, down 484.5% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 25233000.0, up from 43509000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 52475000.0 in Q1 2022, with the low at 1195752000.0 in Q1 2023.
  • Historically, Income from Continuing Operations has averaged 219260352.94 across 5 years, with a median of 65794000.0 in 2022.
  • The largest YoY upside for Income from Continuing Operations was 120.29% in 2022 against a maximum downside of 5346.39% in 2022.
  • Tilray Brands' Income from Continuing Operations stood at 85061000.0 in 2022, then jumped by 45.71% to 46183000.0 in 2023, then sank by 84.65% to 85275000.0 in 2024, then jumped by 48.98% to 43509000.0 in 2025, then soared by 42.01% to 25233000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 25233000.0 (Q1 2026), 43509000.0 (Q4 2025), and 1513000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 370.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -92.12 Mn
10 Tilray Brands - - 54.95 Mn -25.23 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 -25.23 Mn
Nov 30, 2025 -43.51 Mn
Aug 31, 2025 1.51 Mn
May 31, 2025 -613.71 Mn
Feb 28, 2025 -793.53 Mn
Nov 30, 2024 -85.28 Mn
Aug 31, 2024 -34.65 Mn
May 31, 2024 -54.25 Mn
Feb 29, 2024 -104.98 Mn
Nov 30, 2023 -46.18 Mn
Aug 31, 2023 -55.86 Mn
May 31, 2023 -119.82 Mn
Feb 28, 2023 -1.20 Bn
Nov 30, 2022 -85.06 Mn
Aug 31, 2022 -65.79 Mn
May 31, 2022 -457.80 Mn
Feb 28, 2022 52.48 Mn
Nov 30, 2021 5.80 Mn
Aug 31, 2021 -34.60 Mn
May 31, 2021 8.73 Mn